Pharma reflects on pandemic’s ‘aha! moments,’ which spurred new drive for clinical trial diversity
The pharmaceutical industry picked up digital clinical trial tools during the pandemic that can also be used to tackle the lack of diversity in research. So that’s it. The issue is solved.